These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6178812)

  • 1. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
    DuRant RH; Dyken PR; Swift AV
    J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of inosiplex on the survival of subacute sclerosing panencephalitis.
    DuRant RH; Dyken PR
    Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
    Dyken PR; Swift A; DuRant RH
    Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of subacute sclerosing panencephalitis: an overview.
    Taylor WJ; DuRant RH; Dyken PR
    Drug Intell Clin Pharm; 1984 May; 18(5):375-81. PubMed ID: 6202474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.
    Jones CE; Dyken PR; Huttenlocher PR; Jabbour JT; Maxwell KW
    Lancet; 1982 May; 1(8280):1034-7. PubMed ID: 6176821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study.
    Gascon GG;
    J Child Neurol; 2003 Dec; 18(12):819-27. PubMed ID: 14736075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
    Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
    Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
    Nihei K; Kudo H; Abe T; Naito H; Suzuki S; Miyao M
    No To Hattatsu; 1984 Jul; 16(4):262-70. PubMed ID: 6207848
    [No Abstract]   [Full Text] [Related]  

  • 9. Inosiplex in the treatment of subacute sclerosing panencephalitis.
    Silverberg R; Brenner T; Abramsky O
    Arch Neurol; 1979 Jun; 36(6):374-5. PubMed ID: 88215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.
    Noetzel MJ; Dodson WE
    Ann Neurol; 1983 Apr; 13(4):457-60. PubMed ID: 6188412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
    Le Cras R; Mazet R; Dubois-Teklali F; Sabourdy C; Chanoine S; Lehmann A; Morin A; Leenhardt J; Durand M; Desruet MD; Bedouch P
    Emerg Microbes Infect; 2023 Dec; 12(1):2148563. PubMed ID: 36458570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study.
    Anlar B; Yalaz K; Imir T; Turanli G
    Eur Neurol; 1994; 34(1):44-7. PubMed ID: 7511102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
    Haddad FS; Risk WS
    Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine].
    Filipowicz A; Grudzińska B
    Neurol Neurochir Pol; 1987; 21(4-5):352-6. PubMed ID: 2451185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inosiplex for SSPE.
    Jones C
    Lancet; 1982 Aug; 2(8296):495. PubMed ID: 6180266
    [No Abstract]   [Full Text] [Related]  

  • 16. Inosiplex for SSPE.
    Chalmers TC; Smith H
    Lancet; 1982 Jun; 1(8287):1475. PubMed ID: 6177984
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis.
    Yalaz K; Anlar B; Oktem F; Aysun S; Ustacelebi S; Gurcay O; Gucuyener K; Renda Y
    Neurology; 1992 Mar; 42(3 Pt 1):488-91. PubMed ID: 1372397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE).
    Streletz LJ; Cracco J
    Ann Neurol; 1977 Feb; 1(2):183-4. PubMed ID: 70187
    [No Abstract]   [Full Text] [Related]  

  • 19. Isoprinosine in subacute sclerosing panencephalitis.
    Huttenlocher PR; Mattson RH
    Neurology; 1979 Jun; 29(6):763-71. PubMed ID: 88024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report.
    Han CY; Lin HF; Shin PY; Liu CK; Liu CS
    Kaohsiung J Med Sci; 2003 Aug; 19(8):416-20. PubMed ID: 12962429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.